NeuroPace reported a quarterly loss of $0.13 per share, beating the Zacks consensus estimate for a $0.19 loss by $0.06 per share. The result also improved versus a $0.21 loss a year ago, indicating year-over-year earnings progress despite the company remaining unprofitable.
NeuroPace reported a quarterly loss of $0.13 per share, beating the Zacks consensus estimate for a $0.19 loss by $0.06 per share. The result also improved versus a $0.21 loss a year ago, indicating year-over-year earnings progress despite the company remaining unprofitable.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
